In part the National Academies describe long COVID as "a chronic, systemic disease state with profound consequences." The report provides a working definition.
All News
Advertisement
Advertisement
Find details on optimizing diabetes care in primary care settings, benefits of GLP-1RAs for patients with HF and diabetes, and tirzepatide use for obesity-related OSA.
Your daily dose of the clinical news you may have missed.
Global prevalence of adults 65 years and older with T1D increased 180% in the past 30 years, researchers reported.
Your daily dose of the clinical news you may have missed.
The unanimous ruling maintains nationwide access to mifepristone for medical abortion, reversing a lower court's decision to restrict availability.
More than 50% of patients with MASH receiving 1 of 3 doses of tirzepatide achieved MASH resolution without worsening of fibrosis vs placebo, according to data from phase 2 study.
Your daily dose of the clinical news you may have missed.
The high potency IL-5 inhibitor can be administered every 6 months, offering a convenient alternative to other biologic agents for appropriate patients with severe asthma.
Your daily dose of the clinical news you may have missed.
Advertisement
As xylitol is used increasingly to replace sugar in an array of food and other products, Clinic reselinic researchers call for increased scientific scrutiny rchers call for increased scrutiny..
In contrast, men did not face the same increased risk of cerebrovascular disease later in life, reported authors of a new study.
Your daily dose of the clinical news you may have missed.
The FDA has assigned a PDUFA action date of January 25, 2025 for the monthly IV maintenance dose.
The investigational combination vaccine elicited higher immune responses vs licensed comparator vaccines in 2 independent age groups, the company said.
Abbott Secures FDA Clearance for OTC CGMs for General Public, Adults with T2D Who do not Use Insulin
Abbott becomes the second company to receive FDA clearance for an over-the-counter continuous glucose monitoring system.
Your daily dose of the clinical news you may have missed.
GSK announced today approval by the US FDA of a label expansion for the adjuvanted RSV vaccine that adds adults aged 50 to 59 years who are at elevated risk for RSV disease to the vaccine’s current indication.
Your daily dose of the clinical news you may have missed.
There are lots of products in development for weight loss and to treat other metabolic diseases which means more options for more people.
Advertisement
Advertisement
Advertisement
